Analysts believe that recent product launches in India will further solidify Sun Pharmas leading position in the branded ...

India’s branded pharma market is under pressure as Jan Aushadhi and other generic channels gain momentum, impacting volume ...

Over 150 companies are lined up to announce their Q4 results today, making it one of the busiest days in the earnings season. Key players like ITC, Sun Pharma, Grasim, and Honasa Consumer will be in ...

Among healthcare ETFs, VHT stands out in my view as the most representative of the sector, in terms of performance, risk, and ...

Artificial intelligence and robotics are revolutionizing drug discovery by automating laboratory processes and enabling rapid, data-driven breakthroughs. This hybrid approach is cutting costs, ...

A leading fund manager gives his verdict on the growth prospects for CSL shares. The post Should I buy the dip on CSL shares?

The foundations of psychedelic capitalism were largely created by public innovation at the public’s expense and are now in ...

As many as eight important names like ITC, Sun Pharmaceutical Industries, Grasim Industries, GMR Airports, Container ...

The first drugs conceived entirely by artificial intelligence will likely be commercially available around the end of the ...